VOX.BIO
Live / Registered — Registered (as of 20 Aug 2024)
What this means for you
Registered since 20 Aug 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 20 Aug 2030: the §71 affidavit of use).
Record
- Serial number
- 79378221
- Registration number
- 7477344
- Mark type
- Word mark
- Filed
- 03 Jul 2023
- Published for opposition
- 04 Jun 2024
- Registered
- 20 Aug 2024
- Next maintenance filing
- §71 affidavit of use, due by 20 Aug 2030 (grace period to 20 Feb 2031)
- Attorney of record
- PETER J RIEBLING
Goods and services
- Class 035 — Advertising and business services: Providing business advice, information and consultancy for the pharmaceutical, biopharmaceutical and medical device industries; providing business information about pharmaceutical, biopharmaceutical and medical device products and companies; market research for the pharmaceutical, biopharmaceutical and medical device industries; business research and market analysis for the pharmaceutical, biopharmaceutical and medical device industries; business consultancy, namely, strategic consulting and assistance with business decisions in the pharmaceutical, biopharmaceutical and medical device industries; business consultancy, namely, competitor landscaping, competitor monitoring, business competitive intelligence for the pharmaceutical biopharmaceutical and medical device industries; preparing reports on all the aforesaid
- Class 042 — Scientific and technological services: Providing scientific and technological information, advice and consultancy for the pharmaceutical, biopharmaceutical and medical device industries; scientific research consulting, namely, scientific research and analysis for the pharmaceutical, biopharmaceutical and medical device industries; scientific research consulting, namely, scientific and technological landscaping for the pharmaceutical, biopharmaceutical and medical device industries; quality control for others, namely, assessment and benchmarking of pharmaceutical, biopharmaceutical and medical device products; quality control for others, namely, researching, analysing and assessment of pharmaceutical, biopharmaceutical and medical device products for others; providing scientific information about pharmaceutical, biopharmaceutical and medical device products and companies; scientific research consulting, namely, preparing advice and reports on all the aforesaid
Owner
Prosecution history
- 02 Jul 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 07 May 2026 — NEW REPRESENTATIVE AT IB RECEIVED
- 28 Nov 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 01 Mar 2025 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 01 Mar 2025 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
- 13 Feb 2025 — FINAL DISPOSITION NOTICE SENT TO IB
- 13 Feb 2025 — FINAL DISPOSITION PROCESSED
- 10 Feb 2025 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 08 Feb 2025 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
- 21 Nov 2024 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 20 Aug 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 20 Aug 2024 — REGISTERED-PRINCIPAL REGISTER
- 04 Jun 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 04 Jun 2024 — PUBLISHED FOR OPPOSITION
- 15 May 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED